BHVN Biohaven Ltd.

bullish · high conviction track record →
Get emailed when BHVN changes direction
Mkt Cap $2B 52wk $7.48 - $24.06 2h ago
Insider buying: $66,501,582 bought by 8 insiders (30d)
Factor divergence: DIVERGENCE: insider_activity bullish vs estimate_revisions bearish
Est. revisions: -5.9% (2 up, 2 down in 30d)
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net -0.3)

Factor Model

net -0.3 1.2 / 10
Est. Revisions
-0.4
Insider Activity
+0.5
Momentum
+0.0
Analyst Rev.
+0.0
Narrative Gap
+0.0

Biohaven insiders buy $17M, targets rise

Watch: Phase 3 opakalim trial readout in the second half of 2026 will be crucial for validating pipeline progress and driving valuation.

Biohaven insiders made large purchases totaling about $17M recently, including $8M by John Childs and $5M by Vladimir Coric at around $41 per share. Canaccord initiated coverage with a Buy and $21 target; Citi upgraded BHVN's target to $17 from $14. The company focuses on novel therapeutics in obesity, neuroscience, and oncology, with a Phase 3 opakalim trial readout expected H2 2026.

Significant insider buying combined with analyst upgrades signals strong confidence in Biohaven's drug pipeline and near-term catalysts despite the stock's high volatility and ongoing losses.

Evidence

16h ago Insider buy by CAR BRUCE (BHVN): $1,007,490
16h ago Insider buy by CHILDS JOHN W (BHVN): $1,012,983
16h ago Insider buy by BAILEY GREGORY HUGH (BHVN): $220,966
16h ago Insider buy by CORIC VLADIMIR (BHVN): $999,970
16h ago Insider buy by CHILDS JOHN W (BHVN): $999,970
16h ago Insider buy by CHILDS JOHN W (BHVN): $1,042,393
16h ago Insider buy by CHILDS JOHN W (BHVN): $1,002,470
16h ago Insider buy by BAILEY GREGORY HUGH (BHVN): $999,169
7 older signals
16h ago Insider buy by BAILEY GREGORY HUGH (BHVN): $512,877
16h ago Insider buy by CHILDS JOHN W (BHVN): $996,240
16h ago Insider buy by CHILDS JOHN W (BHVN): $996,238
16h ago Insider buy by CLARK GEORGE C. (BHVN): $144,770
16h ago Insider buy by BAILEY GREGORY HUGH (BHVN): $3,000,000
16h ago Insider buy by CHILDS JOHN W (BHVN): $24,999,998
16h ago Insider buy by CORIC VLADIMIR (BHVN): $4,999,995
Fundamentals & Data ▾
Biohaven Ltd. Healthcare · Biotechnology
Mkt Cap
$2B
Beta
3.62
52w Range
$7.48 - $24.06
Short Interest
23.8M 20.25%
Days to Cover
9.2 +13%
Insiders
buying 14B / 0S
EPS Estimate
$-0.76 -5.9% 30d 2up / 2dn
Est. Dispersion
61% 6 analysts
Analyst Target
$22 $9 - $50
Options P/C
0.80
Insider Cluster
strong buy 5B / 0S (officer)
Fund Convergence
moderate Citadel, Two Sigma
Top Holders
Citadel $24M
Two Sigma $4M
Recent Filings & Data
insider trade 26
net buying · $66,501,582 bought
8 insiders · 26 transactions (30d)
Recent transactions
MEHTA KISHAN · other
GENTILE KIMBERLY A · other
CORIC VLADIMIR · other
CAR BRUCE · other
CLARK GEORGE C. · other
BUTEN MATTHEW · other
CLARK GEORGE C. · buy · $144,770
CHILDS JOHN W · buy · $24,999,998
BAILEY GREGORY HUGH · buy · $3,000,000
CORIC VLADIMIR · buy · $4,999,995
CHILDS JOHN W · buy · $996,238
CHILDS JOHN W · buy · $891,769
CHILDS JOHN W · buy · $1,042,393
CHILDS JOHN W · buy · $999,970
CORIC VLADIMIR · buy · $999,970
BAILEY GREGORY HUGH · buy · $220,966
CHILDS JOHN W · buy · $1,012,983
CAR BRUCE · buy · $1,007,490
CHILDS JOHN W · buy · $996,240
CHILDS JOHN W · buy · $1,002,470
BAILEY GREGORY HUGH · buy · $512,877
BAILEY GREGORY HUGH · buy · $999,169
CHILDS JOHN W · buy · $7,999,961
CHILDS JOHN W · buy · $7,674,352
BAILEY GREGORY HUGH · buy · $1,999,980
CORIC VLADIMIR · buy · $4,999,991
15 signals · latest 16h ago

Get alerted when BHVN changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.